Lv3
238 积分 2021-06-03 加入
Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease
1天前
待确认
Glucagon-Like Peptide-1 Receptor Agonist Therapy Does Not Increase Gastrointestinal Adverse Events in Patients with Inflammatory Bowel Disease
1天前
已完结
Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
2天前
已完结
Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans
3天前
已完结
Tezepelumab inhibits highly functional truncated thymic stromal lymphopoietin in chronic rhinosinusitis
3天前
已完结
At The Interface: Small-Molecule Inhibitors of Soluble Cytokines
4天前
已完结
IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms
5天前
已完结
Bridging the inflammation gap by IL-6 inhibition
7天前
已完结
Pathogenic Role of IL-6 Combined with TNF-α or IL-1 in the Induction of Acute Phase Proteins SAA and CRP in Chronic Inflammatory Diseases
7天前
已完结
Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
8天前
已完结
皖公网安备34019202002308
